What type of study is this?

September 10, 2025Deleted JournalOpen Access

Cardiac manifestations of Fabry disease

View Full Paper

Ask AI

Bookmark

Authors

Analysis of cardiac manifestations in fabry disease shows significant prevalence, highlighting the need for genetic testing and effective treatments.

Fabry cardiomyopathy is increasingly recognized as the leading cause of mortality in patients with fabry disease, indicating a need for awareness.
Large-scale studies reveal that fabry disease is more prevalent than previously thought, with the later-onset variant posing significant health challenges.
Genetic testing and advanced imaging tools are crucial for the early diagnosis and assessment of fabry disease and its cardiac manifestations.
Current treatment options include enzyme replacement therapy and pharmacological chaperone therapy, with gene therapy showing promise for future interventions.

Dougherty et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis of cardiac manifestations in fabry disease shows significant prevalence, highlighting the need for genetic testing and effective treatments.